A study to assess the effects of an injection, greater occipital nerve block in the management of neck pain related headache

Phase 1

Completed

• Conditions: Health Condition 1: null- Cervicogenic headache

• Registration Number: CTRI/2018/04/013420
• Lead Sponsor: R G Kar Medical College Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-06-07
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 62

Inclusion Criteria

Unilateral or side-dominant headache without side shift or unilateral both side.

Pain localized to the neck and occipital region and/or projected to forehead, orbital region, temples, vertex or ears.

Restriction of the range of motion (ROM) in the neck.

Ipsilateral neck, shoulder, or arm pain of non-radicular or radicular nature.

Precipitation of headache by neck movement and/or sustained awkward head positioning .

Precipitation of headache by external pressure over the upper cervical or occipital region on the symptomatic side.

Radiological examination reveals Movement abnormalities in flexion/extension or Abnormal posture

Headache for the past 3 months at least once per week .

No improvement of headache with conservative managements.

Improvement of pain within 30 minutes of diagnostic greater occipital nerve block.

Exclusion Criteria

Congenital abnormalities of the cervical spine .

Radiological evidence of cervical spondylosis or osteochondrosis .

Myofascial trigger points are the cause .

Contraindication or History of adverse reaction to anesthetic agents or corticosteroids .

Prior intervention or surgery for treatment of headache .

Evidence of impaired sensation in the Greater occipital nerve dermatome region .

Evidence of cranial defect/abnormality near target injection site .

Untreated cutaneous infection, systemic illness, or immunocompromised state

History of bleeding tendency or use of anticoagulants .

Patientâ??s refusal.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain severity Numeric Rating ScaleTimepoint: 1 Week <br/ ><br>4 Weeks

Secondary Outcome Measures

Name	Time	Method
Pain severity Numeric Rating ScaleTimepoint: 12 Weeks